Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2368229
Max Phase: Preclinical
Molecular Formula: C60H100O14Si2
Molecular Weight: 1101.62
Molecule Type: Unknown
Associated Items:
ID: ALA2368229
Max Phase: Preclinical
Molecular Formula: C60H100O14Si2
Molecular Weight: 1101.62
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@@H](OC)[C@@H](O[C@H]4C[C@@H](OC)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O[Si](C)(C)C(C)(C)C)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2
Standard InChI: InChI=1S/C60H100O14Si2/c1-21-35(2)51-38(5)27-28-59(72-51)33-44-30-43(71-59)26-25-37(4)50(36(3)23-22-24-42-34-65-55-52(73-75(17,18)57(9,10)11)39(6)29-45(56(61)68-44)60(42,55)62)69-48-31-46(63-15)53(40(7)66-48)70-49-32-47(64-16)54(41(8)67-49)74-76(19,20)58(12,13)14/h22-25,27-29,35-36,38,40-41,43-55,62H,21,26,30-34H2,1-20H3/b23-22+,37-25+,42-24+/t35-,36-,38-,40-,41-,43+,44-,45-,46+,47+,48-,49-,50-,51+,52+,53-,54-,55+,59+,60+/m0/s1
Standard InChI Key: DEQDHRIBEMNOJS-NRJQPXADSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1101.62 | Molecular Weight (Monoisotopic): 1100.6652 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Mrozik H, Eskola P, Fisher MH, Egerton JR, Cifelli S, Ostlind DA.. (1982) Avermectin acyl derivatives with anthelmintic activity., 25 (6): [PMID:7097720] [10.1021/jm00348a010] |
Source(1):